Clinical Trial Update: Colombia Epidemiologic Surveillance Study

View source ↗

Summary

Pfizer-sponsored Colombia Epidemiologic Surveillance Study has been terminated. The study investigated Pneumonia, Meningitis, Bacteremia, and Sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Meningitis
• Pneumonia
• Sepsis

Snippet

Sponsor: Pfizer | Conditions: Pneumonia, Meningitis | Status: TERMINATED